MAPT and Alzheimer disease: Thus, a prenatal immune challenge is sufficient to trigger a series of neuropathologic events that lead to a slow but gradual increase in amyloidogenic APP processing, Tau hyperphosphorylation and mislocalization, and cognitive impairments, potentially representing a state of increased vulnerability of the brain to AD.